MENU
+Compare
SHPMY
Stock ticker: OTC
AS OF
Dec 18 closing price
Price
$8.00
Change
-$0.75 (-8.57%)
Capitalization
9.5B

SHPMY stock forecast, quote, news & analysis

SHPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
A.I.Advisor
a Summary for SHPMY with price predictions
Dec 20, 2024

SHPMY in downward trend: price dove below 50-day moving average on December 18, 2024

SHPMY moved below its 50-day moving average on December 18, 2024 date and that indicates a change from an upward trend to a downward trend. In of 66 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for SHPMY turned negative on December 18, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 58 similar instances when the indicator turned negative. In of the 58 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SHPMY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SHPMY broke above its upper Bollinger Band on December 09, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on December 20, 2024. You may want to consider a long position or call options on SHPMY as a result. In of 105 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SHPMY advanced for three days, in of 126 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 195 cases where SHPMY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.716) is normal, around the industry mean (7.608). P/E Ratio (8.389) is within average values for comparable stocks, (28.511). Projected Growth (PEG Ratio) (2.467) is also within normal values, averaging (4.521). Dividend Yield (0.045) settles around the average of (0.032) among similar stocks. P/S Ratio (0.204) is also within normal values, averaging (33.632).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SHPMY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SHPMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

A.I.Advisor
published Dividends

SHPMY paid dividends on November 12, 2024

Shanghai Pharmaceuticals Holdings Co., Ltd. SHPMY Stock Dividends
А dividend of $0.06 per share was paid with a record date of November 12, 2024, and an ex-dividend date of September 19, 2024. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are McKesson Corp (NYSE:MCK).

Industry description

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

Market Cap

The average market capitalization across the Medical Distributors Industry is 9.87B. The market cap for tickers in the group ranges from 494.39K to 70.55B. MCK holds the highest valuation in this group at 70.55B. The lowest valued company is SNYR at 494.39K.

High and low price notable news

The average weekly price growth across all stocks in the Medical Distributors Industry was 1%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 147%. SHPMF experienced the highest price growth at 33%, while COSM experienced the biggest fall at -19%.

Volume

The average weekly volume growth across all stocks in the Medical Distributors Industry was 242%. For the same stocks of the Industry, the average monthly volume growth was 170% and the average quarterly volume growth was 21%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 55
Price Growth Rating: 57
SMR Rating: 79
Profit Risk Rating: 78
Seasonality Score: 34 (-100 ... +100)
View a ticker or compare two or three
SHPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry MedicalDistributors

Profile
Fundamentals
Details
Industry
N/A
Address
No. 200 Taicang Road
Phone
+86 2163730908
Employees
47877
Web
https://www.sphchina.com